Because of the critical roles played by DNA repair genes/proteins in tumorigenesis and cancer therapy, we developed the DRMB platform to quantitatively measure the activity of select DNA repair proteins and DNA repair capacity of cells/tissues. Here, XRCC6P5 is linked to cancer.